Alan Minsk Quoted in Bloomberg Law on FDA's Online Misinformation Draft Guidance

AGG Food & Drug chair Alan Minsk was quoted in an article published by Bloomberg Law on September 30, 2024, discussing FDA’s revised draft guidance on how medical product manufacturers should respond to false or misleading information on social media.

While the guidance creates a broader path for firms to respond to misinformation, companies are still cautious in their responses as they must adhere to FDA rules and regulations.

“The issues are typically about liability,” said Alan. “All of a sudden someone turns this into a promotional opportunity — you might get into false or misleading information.”

To read the full article, please click here.